114 million shares at 4.13, page-10

Maple Brown Abbott (last notice: 10.97%) and Barclays (last notice: 6.24%) are the only shareholders who are even close to the 7.8% which that sale represents.

Of course, there is IOOF, however they've just finished topping up to 9.63%, so that'd have to be doubtful.

I go for Maple Brown Abbott for the following reasons:-

* When I look at MBA's funds, I don't see any major holdings in BLY declared in the fact sheets for its Aussie funds.
* According to this article, Robert Maple-Brown's son, Dougal has been cutting his teeth at Dad's business, managing the Advance Imputation Fund.
* According to the Advance Quarterly Performance Report for Dec 08, they were overweight BLY.
* Reducing your dividend to zero and not giving 2009 earnings guidance means you probably won't be adding too much to an imputation fund's holdings for the foreseeable future.